SIGA Technologies Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIGA Technologies Inc.

SIGA 8.410

+3.4%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: RikRichter	11/14/2006 12:46:06 PM
	Read Replies (1) of 160

From Wall Street Reporter today: SIGA Technologies (NASDAQ: SIGA) has cultivated a “dominant” position in the field of countermeasures against various biological threats, says acting CEO Thomas N. Konatich. The company’s smallpox program has a demonstrated safety profile and efficacy in primate models and as such “is sort of the gold standard of protection” at the moment, Mr. Konatich says. Other programs are in the pipeline. Between grants, contracts, and a recent $9 million private placement, the company is adequately funded to meet near-term development goals. According to Dr. Dennis E. Hruby, chief scientific officer, target markets have “a great likelihood” of being global in scale. Click to Listen: wallstreetreporter.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next